Unknown

Dataset Information

0

An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.


ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease-19 (COVID-19) pandemic, was identified in late 2019 and caused >5 million deaths by February 2022. To date, targeted antiviral interventions against COVID-19 are limited. The spectrum of SARS-CoV-2 infection ranges from asymptomatic to fatal disease. However, the reasons for varying outcomes to SARS-CoV-2 infection are yet to be elucidated. Here we show that an endogenously activated interferon lambda (IFNλ1) pathway leads to resistance against SARS-CoV-2 infection. Using a well-differentiated primary nasal epithelial cell (WD-PNEC) culture model derived from multiple adult donors, we discovered that susceptibility to SARS-CoV-2 infection, but not respiratory syncytial virus (RSV) infection, varied. One of four donors was resistant to SARS-CoV-2 infection. High baseline IFNλ1 expression levels and associated interferon stimulated genes correlated with resistance to SARS-CoV-2 infection. Inhibition of the JAK/STAT pathway in WD-PNECs with high endogenous IFNλ1 secretion resulted in higher SARS-CoV-2 titres. Conversely, prophylactic IFNλ treatment of WD-PNECs susceptible to infection resulted in reduced viral titres. An endogenously activated IFNλ response, possibly due to genetic differences, may be one explanation for the differences in susceptibility to SARS-CoV-2 infection in humans. Importantly, our work supports the continued exploration of IFNλ as a potential pharmaceutical against SARS-CoV-2 infection.

SUBMITTER: Broadbent L 

PROVIDER: S-EPMC9015133 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.

Broadbent Lindsay L   Bamford Connor G G CGG   Lopez Campos Guillermo G   Manzoor Sheerien S   Courtney David D   Ali Ahlam A   Touzelet Olivier O   McCaughey Conall C   Mills Ken K   Power Ultan F UF  

PloS one 20220418 4


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease-19 (COVID-19) pandemic, was identified in late 2019 and caused >5 million deaths by February 2022. To date, targeted antiviral interventions against COVID-19 are limited. The spectrum of SARS-CoV-2 infection ranges from asymptomatic to fatal disease. However, the reasons for varying outcomes to SARS-CoV-2 infection are yet to be elucidated. Here we show that an endogenously activated interferon lam  ...[more]

Similar Datasets

2022-04-05 | GSE199743 | GEO
| PRJNA821420 | ENA
2021-05-03 | ST001774 | MetabolomicsWorkbench
| S-EPMC6529648 | biostudies-literature
2020-07-21 | GSE153970 | GEO
| S-EPMC4593539 | biostudies-literature
| S-EPMC8397300 | biostudies-literature
| S-EPMC9144593 | biostudies-literature
| S-EPMC6521319 | biostudies-literature
| S-EPMC4338293 | biostudies-literature